Micro Emerging Active

MeiraGTx FDA breakthrough pour le traitement de la xérostomie

New narrative with limited coverage — still forming.

Score
0,2
Vélocité
▲ 0,0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Mar 26, 2026
MeiraGTx Stock Gains 5% Over Narrower Loss In FY25, FDA Breakthrough Designation … Neutral

Chronologie

Première observationMar 26, 2026
Dernière mise à jourMar 26, 2026